PNEUMOCYSTIS
Clinical trials for PNEUMOCYSTIS explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCYSTIS trials appear
Sign up with your email to follow new studies for PNEUMOCYSTIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Trial challenges 3-Week steroid rule for deadly pneumonia
Disease control Not yet recruitingThis study aims to find the best length of steroid treatment for adults with weakened immune systems who have a severe lung infection called PCP. It will compare stopping steroids after 10 days (if the patient has recovered enough) to the standard 21-day course. The goal is to se…
Matched conditions: PNEUMOCYSTIS
Phase: PHASE4 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Doctors seek better options for dangerous lung infection when standard treatment fails
Disease control Not yet recruitingThis study aims to find the best alternative treatment for Pneumocystis pneumonia (PCP), a serious lung infection that affects people with weakened immune systems. When the standard antibiotic treatment can't be used due to allergies, side effects, or poor response, doctors curre…
Matched conditions: PNEUMOCYSTIS
Phase: PHASE4 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC